Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Letter to the Editor: "Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH".

Literature DB >> 30247553

Letter to the Editor: "Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH".

Xiaobin Han¹, L Darryl Quarles¹.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2018 PMID： 30247553 PMCID： PMC6195674 DOI： 10.1210/en.2018-00690

Source DB: PubMed Journal: Endocrinology ISSN： 0013-7227 Impact factor: 4.736

Keyword Cloud
References

× No keyword cloud information.

10 in total

1. FGF23 induces left ventricular hypertrophy.

Authors: Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal: J Clin Invest Date: 2011-10-10 Impact factor: 14.808

2. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.

Authors: Alexander Grabner; Ansel P Amaral; Karla Schramm; Saurav Singh; Alexis Sloan; Christopher Yanucil; Jihe Li; Lina A Shehadeh; Joshua M Hare; Valentin David; Aline Martin; Alessia Fornoni; Giovana Seno Di Marco; Dominik Kentrup; Stefan Reuter; Anna B Mayer; Hermann Pavenstädt; Jörg Stypmann; Christian Kuhn; Susanne Hille; Norbert Frey; Maren Leifheit-Nestler; Beatrice Richter; Dieter Haffner; Reimar Abraham; Johannes Bange; Bianca Sperl; Axel Ullrich; Marcus Brand; Myles Wolf; Christian Faul
Journal: Cell Metab Date: 2015-10-01 Impact factor: 27.287

3. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.

Authors: Jian Xie; Joonho Yoon; Sung-Wan An; Makoto Kuro-o; Chou-Long Huang
Journal: J Am Soc Nephrol Date: 2014-12-04 Impact factor: 10.121

4. Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study.

Authors: Nao Souma; Tamara Isakova; David Lipiszko; Ralph L Sacco; Mitchell S V Elkind; Janet T DeRosa; Shonni J Silverberg; Armando J Mendez; Chuanhui Dong; Clinton B Wright; Myles Wolf
Journal: J Clin Endocrinol Metab Date: 2016-08-08 Impact factor: 5.958

5. Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene.

Authors: Xiaobin Han; Jed Ross; Ganesh Kolumam; Min Pi; Junichiro Sonoda; Gwendalyn King; L Darryl Quarles
Journal: J Am Soc Nephrol Date: 2017-10-09 Impact factor: 10.121

6. Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH.

Authors: Eva S Liu; Robrecht Thoonen; Elizabeth Petit; Binglan Yu; Emmanuel S Buys; Marielle Scherrer-Crosbie; Marie B Demay
Journal: Endocrinology Date: 2018-05-01 Impact factor: 4.736

7. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.

Authors: Shiguang Liu; Wen Tang; Jianping Zhou; Luke Vierthaler; L Darryl Quarles
Journal: Am J Physiol Endocrinol Metab Date: 2007-09-11 Impact factor: 4.310